SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-09-000065
Filing Date
2009-08-14
Accepted
2009-08-14 10:18:21
Documents
2
Period of Report
2009-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DOR 8K FINANCIAL RESULTS 2Q 09 form8k.htm 8-K 24658
2 DOR PRESS RELEASE 2Q 09 ex99_1.htm EX-99.1 19700
  Complete submission text file 0000812796-09-000065.txt   46083
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-452-0001
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 091012779
SIC: 2834 Pharmaceutical Preparations